Skip to main content
. 2016 Sep 10;110(2):73–81. doi: 10.1093/qjmed/hcw151

Table 1.

Baseline demographics of overall and transplanted cohort of patients

Total cohort of patients Valid n HCV (n = 275) NAFLD (n = 212) P-value
Agea 487 58.6 (10.2) 69.6 (8.7) <0.001*a
BMIa 336 26.5 (5.2) 32.3 (5.6) <0.001*a
Gender (Male) 487 219 (79.6%) 171 (80.7%) 0.820
Ethnicity 487 <0.001*
White 198 (72.0%) 208 (98.1%)
Asian 66 (24.0%) 3 (1.4%)
Black/Mixed 11 (4.0%) 1 (0.5%)
DM (type 2) 487 65 (23.6%) 153 (72.2%) <0.001*
Alcohol Excess 487 50 (18.2%) 29 (13.7%) 0.215
Cirrhotic 487 271 (98.5%) 185 (87.3%) <0.001*
MELDb 287 9 (7 – 11) 10 (8 – 13) 0.142b
Albumina 288 37.2 (6.0) 39.3 (5.6) 0.006*a

Transplanted cohort of patients Valid n HCV (n=80) NAFLD (n=21) P-value

Agea 101 54.0 (7.2) 58.9 (5.5) 0.005*a
BMIa 98 26.9 (4.5) 32.1 (5.0) <0.001*a
Gender (Male) 101 69 (86%) 18 (86%) 1.000
Ethnicity 101 0.012*
 White 58 (73%) 21 (100%)
 Asian 20 (25%) 0 (0%)
 Black/Mixed 2 (3%) 0 (0%)
DM (type 2) 101 27 (34%) 16 (76%) <0.001*
Alcohol Excess 101 10 (13%) 6 (29%) 0.094
MELDb 101 8 (7–11) 10 (8–15) 0.024*b
Albumina 101 37.9 (5.8) 35.9 (7.3) 0.177a

Data reported as ‘n (%)’, with P-values from Fisher’s exact test, unless stated otherwise.

aData reported as ‘Mean (SD)’, with P-values from independent samples t-tests.

bData reported as ‘Median (Quartiles)’, with P-values from Mann–Whitney tests.

*

Significant at P < 0.05.